281 related articles for article (PubMed ID: 1641071)
61. Effect of vasoactive intestinal peptide (VIP) on the release of adenohypophyseal hormones from purified cells obtained by unit gravity sedimentation. Inhibition by dexamethasone of vip-induced prolactin release.
Rotsztejn WH; Benoist L; Besson J; Beraud G; Bluet-Pajot MT; Kordon C; Rosselin G; Duval J
Neuroendocrinology; 1980 Oct; 31(4):282-6. PubMed ID: 7422069
[TBL] [Abstract][Full Text] [Related]
62. Anterior pituitary vasoactive intestinal peptide mRNA is colocalised with prolactin mRNA in hyperoestrogenised rats.
Chew LJ; Seah V; Murphy D; Carter D
J Mol Endocrinol; 1996 Jun; 16(3):211-20. PubMed ID: 8782079
[TBL] [Abstract][Full Text] [Related]
63. Peptide contents of neuropeptide Y, vasoactive intestinal polypeptide, and beta-calcitonin gene-related peptide and their messenger ribonucleic acids after dexamethasone treatment in the isolated rat islets of Langerhans.
Jamal H; Jones PM; Byrne J; Suda K; Ghatei MA; Kanse SM; Bloom SR
Endocrinology; 1991 Dec; 129(6):3372-80. PubMed ID: 1954911
[TBL] [Abstract][Full Text] [Related]
64. [The effects of short and long duration of hypothyroidism on prolactin secretion in rats].
Mizukami M; Kishida S; Hirai M; Ooya E; Nakai T; Miyabo S
Nihon Naibunpi Gakkai Zasshi; 1993 Dec; 69(11):1129-38. PubMed ID: 8293854
[TBL] [Abstract][Full Text] [Related]
65. Vasoactive intestinal peptide levels in the hypothalamus and anterior pituitary do not change in association with the pre-ovulatory prolactin surge in the rat.
Watanobe H; Sasaki S; Takebe K
Neuropeptides; 1991 Nov; 20(3):159-62. PubMed ID: 1762665
[TBL] [Abstract][Full Text] [Related]
66. Influence of adrenal glands on the modulation of prolactin gene expression by the endogenous benzodiazepine ligand octadecaneuropeptide in the male rat pituitary gland.
Wang H; Li S; Givalois L; Pelletier G
J Neuroendocrinol; 1998 Mar; 10(3):193-8. PubMed ID: 9576607
[TBL] [Abstract][Full Text] [Related]
67. Vasoactive intestinal polypeptide and dopamine in the hypothalamus and pituitary of ageing rats with prolactinomas.
Prysor-Jones RA; Silverlight JJ; Jenkins JS; Merry BJ
Acta Endocrinol (Copenh); 1987 Sep; 116(1):150-4. PubMed ID: 3661055
[TBL] [Abstract][Full Text] [Related]
68. Tissue-specific regulation of vasoactive intestinal peptide messenger ribonucleic acid levels by estrogen in the rat.
Kasper S; Popescu RA; Torsello A; Vrontakis ME; Ikejiani C; Friesen HG
Endocrinology; 1992 Apr; 130(4):1796-801. PubMed ID: 1547709
[TBL] [Abstract][Full Text] [Related]
69. Osmotic stimuli attenuate vasoactive intestinal peptide gene expression in the rat anterior pituitary gland.
Chew LJ; Pardy K; Murphy D; Carter DA
Mol Cell Endocrinol; 1993 Mar; 92(1):9-14. PubMed ID: 8472872
[TBL] [Abstract][Full Text] [Related]
70. Stimulation of growth hormone release by vasoactive intestinal peptide and peptide PHI in rat anterior pituitary reaggregates. Permissive action of a glucocorticoid and inhibition by thyrotropin-releasing hormone.
Denef C; Schramme C; Baes M
Neuroendocrinology; 1985 Jan; 40(1):88-91. PubMed ID: 3918279
[TBL] [Abstract][Full Text] [Related]
71. Neuroendocrine significance of vasoactive intestinal polypeptide.
Reichlin S
Ann N Y Acad Sci; 1988; 527():431-49. PubMed ID: 2898911
[TBL] [Abstract][Full Text] [Related]
72. Developmental expression of the VIP-gene in brain and intestine.
Gozes I; Shani Y; Rostène WH
Brain Res; 1987 Jul; 388(2):137-48. PubMed ID: 2441796
[TBL] [Abstract][Full Text] [Related]
73. Presence of immunoreactive vasoactive intestinal polypeptide in anterior pituitary of normal male and long term estrogen-treated female rats: a light microscopic immunohistochemical study.
Köves K; Gottschall PE; Görcs T; Scammell JG; Arimura A
Endocrinology; 1990 Mar; 126(3):1756-63. PubMed ID: 1689657
[TBL] [Abstract][Full Text] [Related]
74. Adenohypophyseal vasoactive intestinal peptide and neuropeptide Y responses to hypothyroidism are abolished after anterolateral deafferentation of the hypothalamus.
Michalkiewicz M; Suzuki M
Neuroendocrinology; 1994 Jan; 59(1):85-91. PubMed ID: 8145898
[TBL] [Abstract][Full Text] [Related]
75. Antisera to vasoactive intestinal polypeptide inhibit basal prolactin release from dispersed anterior pituitary cells.
Hagen TC; Arnaout MA; Scherzer WJ; Martinson DR; Garthwaite TL
Neuroendocrinology; 1986; 43(6):641-5. PubMed ID: 3762862
[TBL] [Abstract][Full Text] [Related]
76. Differential regulation of type II corticosteroid receptor messenger ribonucleic acid expression in the rat anterior pituitary and hippocampus.
Sheppard KE; Roberts JL; Blum M
Endocrinology; 1990 Jul; 127(1):431-9. PubMed ID: 2361479
[TBL] [Abstract][Full Text] [Related]
77. Hypothalamic vasoactive intestinal peptide messenger ribonucleic acid is increased in lactating rats.
Gozes I; Shani Y
Endocrinology; 1986 Dec; 119(6):2497-501. PubMed ID: 3780537
[TBL] [Abstract][Full Text] [Related]
78. [Postnatal lactotropic hypoactivity in rats: possible implication of VIP, endogenous opioids, dopamine and glucocorticoids].
El Feki A; Sakly M; Kamoun A
Ann Endocrinol (Paris); 1996; 57(2):129-34. PubMed ID: 8881293
[TBL] [Abstract][Full Text] [Related]
79. Onset of glucocorticoid responsiveness of anterior pituitary corticotrophs during development is scheduled by corticotropin-releasing factor.
Grino M; Burgunder JM; Eskay RL; Eiden LE
Endocrinology; 1989 Jun; 124(6):2686-92. PubMed ID: 2524376
[TBL] [Abstract][Full Text] [Related]
80. Vasoactive intestinal peptide modulates luteinizing hormone subunit gene expression in the anterior pituitary in female rat.
Gajewska A; Wolińska-Witort E; Kochman K
Brain Res Bull; 2005 Oct; 67(4):319-26. PubMed ID: 16182940
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
